The 3D spheroid-based invasion assays of glioma stem cells also revealed that knockdown of CDC42 or treatment with the CDC42 specific inhibitor ZCL278 inhibited the invasion-promoting effect of TRIM56 in glioma cells (Supplementary Fig. 6B). The gene discussed is TRIM56; the disease is central nervous system cancer.